Editor’s be aware: A livestream of the dialog will likely be embedded beneath at 1 p.m. ET.
Every week, week, STAT+ subscribers get entry to unique conversations with biotech, pharma, and well being tech leaders. This week, STAT normal project reporter and affiliate editorial director of occasions Nicholas St. Fleur will likely be joined by Fouad Namouni, president of analysis and improvement at Blueprint Medicines. They are going to be discussing Blueprint’s work in making focused most cancers medicine, the way forward for oncology, and naturally be taking your questions reside.